Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Allergan plc (NYSE:AGN)

167.80
Delayed Data
As of Dec 08
 +2.93 / +1.78%
Today’s Change
160.07
Today|||52-Week Range
256.80
-20.10%
Year-to-Date
Weekly Top Insider Buys Highlight for the Week of Dec. 8
Dec 10 / GuruFocus News - Paid Partner Content
Allergan Ends Positive After Sell-Off; Walgreens, Fred's Make Moves -- ICYMI
Dec 06 / TheStreet.com - Paid Partner Content
3 Drug/Biotech Stocks Up More Than 10% This Week
Dec 08 / Zacks.com - Paid Partner Content
U.S. Concrete: Cramer's Top Takeaways
Dec 06 / TheStreet.com - Paid Partner Content
Allergan Plc (AGN) Chairman, President and CEO Brent L Saunders Bought $757,804 of Sh...
Dec 07 / GuruFocus News - Paid Partner Content
What to Worry About for 2018: Cramer's 'Mad Money' Recap (Wednesday 12/6/17)
Dec 06 / TheStreet.com - Paid Partner Content
Quick News on Goldman, Allergan
Dec 07 / TheStreet.com - Paid Partner Content
Roche's Avastin Gets Full FDA Approval for Brain Cancer
Dec 06 / Zacks.com - Paid Partner Content
Outlook for Autodesk: Cramer's Top Takeaways
Dec 06 / TheStreet.com - Paid Partner Content
Revance's Neuromodulator Injection Positive in Phase III
Dec 06 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close164.87
Today’s open166.11
Day’s range164.58 - 168.78
Volume2,881,904
Average volume (3 months)3,322,299
Market cap$55.8B
Dividend yield1.67%
Data as of 4:02pm ET, 12/08/2017

Growth & Valuation

Earnings growth (last year)+281.42%
Earnings growth (this year)+20.25%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)-3.32%
P/E ratioNM
Price/Sales5.55
Price/Book0.79

Competitors

 Today’s
change
Today’s
% change
AZNAstraZeneca+0.52+1.61%
ABTAbbott Laboratories-0.05-0.09%
LLYEli Lilly and Co+0.58+0.68%
NVONovo Nordisk+0.61+1.18%
Data as of 4:02pm ET, 12/08/2017

Financials

Next reporting dateFebruary 21, 2018
EPS forecast (this quarter)$4.74
Annual revenue (last year)$14.6B
Annual profit (last year)$15.0B
Net profit margin-6.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts